[ad_1] New study data also confirm STELARA's effectiveness® (Ustekinumab) in tumor necrosis factor (TNF) antagonist-naive patients or those who do not tolerate this Janssen Pharmaceuticals of Johnson & Johnson today announced new …
Read More »IRW News: Sernova Corp. : Sernova Launches Patient Selection and Recruitment for US Diabetes Clinical Study ()
[ad_1] IRW-PRESS: Sernova Corp. : Sernova Launches Patient Selection and Recruitment for US Diabetes Clinical Study Sernova Launches Patient Selection and Recruitment for US Diabetes Clinical Study LONDON, ONTARIO , July 5, …
Read More »Sernova Launches Patient Selection and Recruitment for US Diabetes Clinical Study
[ad_1] Sernova launches selection of patients and R recruitment for his clinical study on diabetes in the United States LONDON, ONTARIO, on 5. July 2018 – Sernova Corp. (" Sernova " or …
Read More »